Nyxoah (NASDAQ:NYXH) vs. Rennova Health (OTCMKTS:RNVA) Financial Analysis

Rennova Health (OTCMKTS:RNVA) and Nyxoah (NASDAQ:NYXH) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Rennova Health and Nyxoah, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rennova Health	0	0	0	0	0.00
Nyxoah	1	0	3	1	2.80

Nyxoah has a consensus price target of $11.67, suggesting a potential upside of 281.26%. Given Nyxoah’s stronger consensus rating and higher probable upside, analysts plainly believe Nyxoah is more favorable than Rennova Health.

Volatility & Risk

Rennova Health has a beta of 22.86, suggesting that its stock price is 2,186% more volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.56, suggesting that its stock price is 56% more volatile than the S&P 500.

Profitability

This table compares Rennova Health and Nyxoah’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Rennova Health	N/A	N/A	N/A
Nyxoah	-1,457.97%	-101.99%	-66.74%

Valuation & Earnings

This table compares Rennova Health and Nyxoah”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rennova Health	$18.69 million	0.00	-$7.73 million	N/A	N/A
Nyxoah	$5.64 million	18.48	-$64.10 million	($2.49)	-1.23

Rennova Health has higher revenue and earnings than Nyxoah.

Summary

Rennova Health beats Nyxoah on 6 of the 10 factors compared between the two stocks.

About Rennova Health

Rennova Health, Inc., together with its subsidiaries, provides health care services in the United States. It owns one operating hospital in Oneida, Tennessee; and a rural clinic in Williamsburg, Kentucky. The company is based in West Palm Beach, Florida.

About Nyxoah

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.